PDPK1 and non-small cell lung carcinoma: For instance, Zhou et al. reported that hsa_circ_0004015 contributed to disease progression and gefitinib resistance in NSCLC patients; mechanistically, circ_0004015 sponged miR-1183 and subsequently targeted 3-phosphoinositide dependent protein kinase 1 (PDPK1) (245).